NABCONS invites applications for 22 senior and junior consultant posts; apply at nabcons.com

-

NABARD Consultancy Services (NABCONS) has started the recruitment drive for the posts of Senior Consultants and Junior Consultants on a contractual basis. The selected candidates will be posted as project-based contract staff and will be responsible for the effective implementation and monitoring of 'Off Farm Development Department' (OFDD) projects in 18 states.

OFDD works in collaboration with different departments and organisations like Off Farm Producers' Organization (OFPOs). It works for skill development, marketing initiatives, GI, rural innovation, rural Incubation, etc.  Initially, the contract will be for one year which can be extended as per the requirements of the project. Those who wish to apply can do it by visiting the official website. The last date to apply is 29 May.

Aspirants can follow these simple steps to apply:

- Visit the website

- On the homepage, click on the ‘Join Hands with NABCONS’ link

- A new page will open. Tap on the ‘New Jobs Hiring for Long Term Basis’ link

- Now, click on the job notification

- Read all the important instructions, eligibility, etc. carefully

- Click on the link of the post you want to apply for

- Fill the Google form and submit it

For Senior Consultant posts, apply here:

For Junior Consultant posts, apply here:

Vacancy details:

Total - 22

Senior Consultants - 2

Junior Consultants – 20

Candidates selected for the Senior Consultants posts will be posted only at the NABARD head office in Mumbai.

Age limit:

Senior Consultants: A candidate must be between 40 to 50 years of age. The age limit can be relaxed for the deserving candidates after approval from OFFD Head Office

Junior Consultants: Minimum 25 years and maximum 35 years. The relaxation of age is the same as for Senior Consultants

Shortlisted candidates will be called for an interview round. It can be in-person or virtual. They can also be assessed for MS Office/ data management proficiency.



from Firstpost India Latest News https://ift.tt/2S1UwcO
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated....
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu...
Read more